How Long After a Prostate Biopsy Can You Get an Infection?

Most infections after a prostate biopsy appear within the first three days, and the vast majority surface within the first week. In one multicenter cohort study, roughly nine out of ten sepsis cases occurred within seven days of the procedure.¹ That said, delayed infections can occasionally emerge weeks later, sometimes in places you would never associate with a prostate procedure. Understanding the window of risk, and the warning signs that should send you to an emergency room, matters more than the odds suggest.

When Infections Typically Appear

The bacteria responsible for post-biopsy infections are almost certainly introduced during the procedure itself, and the body’s response tends to be swift. Research consistently shows that clinical symptoms cluster in a tight window around the first one to three days. One study of post-biopsy sepsis cases found the median time to symptom onset was two days, with a range stretching as far as 22 days in rare outliers.¹ A broader study tracking infectious symptoms after biopsy found them appearing within one week in virtually all cases.²

So the practical answer is this: the danger zone is the first seven days, with the highest-risk window being the first 72 hours. If you make it to day seven feeling well, you can relax considerably. But if you develop a fever, chills, difficulty urinating, or feel genuinely unwell at any point in that first week, treat it as potentially serious and get evaluated promptly.

How Bacteria Get In

The explanation for that tight infection window has to do with how the biopsy is performed. In a transrectal biopsy, which has historically been the most common approach, the needle passes through the wall of the rectum to reach the prostate. Each pass can push rectal bacteria directly into the prostate gland, surrounding blood vessels, or the urinary tract. Without antibiotic prophylaxis, studies have documented bacteremia (bacteria in the bloodstream) in anywhere from about 16% to 75% of patients immediately afterward, and bacteria in the urine in roughly a third to half of patients.³ The body either clears those bacteria quickly, or an infection takes hold. That is why symptoms tend to show up fast.

Transperineal biopsies, where the needle enters through the skin between the scrotum and the anus instead of through the rectum, avoid this direct inoculation route. The needle never crosses the bacteria-laden rectal wall, which dramatically lowers the chance of infection.

What Kind of Infections Can Develop

Post-biopsy infections are not all the same, and they range from mildly annoying to life-threatening. The most common types include urinary tract infections, bacteriuria (bacteria in the urine without major symptoms), acute prostatitis (a painful infection of the prostate gland itself), epididymitis (infection of the tube behind the testicle), bacteremia, and, at the severe end, sepsis.⁴ Infectious complications have actually overtaken all other types of biopsy-related complications, including bleeding, as the most common problem requiring hospitalization.

Most infections stay in the urinary tract and respond to antibiotics. Sepsis, where the infection spreads into the bloodstream and triggers a dangerous whole-body inflammatory response, is rarer but is the complication that puts patients in intensive care. When sepsis does develop after a prostate biopsy, hospital stays can range from just over one day to two weeks, and between about 1% and 25% of sepsis cases require ICU admission.⁵

Warning Signs That Need Immediate Attention

After a biopsy, some discomfort, light rectal bleeding, and blood in the urine or semen are normal and expected for days or even weeks. Infection is different. The signs that should prompt you to seek emergency care include:

Fever: a temperature of 38°C (100.4°F) or higher, especially with chills or shaking
Urinary symptoms: burning, frequency, urgency, or inability to urinate, particularly when combined with fever
Feeling systemically unwell: confusion, rapid heartbeat, light-headedness, or a general sense that something is seriously wrong
Pain: worsening pain in the perineum, lower abdomen, or lower back that is not improving

Fever with chills in the first few days after a biopsy is the classic red flag for urosepsis. Do not wait it out or assume it is just a reaction to the procedure. The bacteria involved grow quickly and can overwhelm the body’s defenses in hours.

Transrectal Versus Transperineal Biopsy

The shift toward transperineal biopsy in urology is driven in large part by infection risk. In the PREVENT randomized trial, the transperineal group had zero infections, compared with a 1.6% infection rate in the transrectal group.⁶ A systematic review and meta-analysis pooling data from multiple trials found that transperineal biopsy was associated with roughly 77% lower odds of hospital admission for infection. The absolute hospitalization risk for infection was about 0.03% for transperineal compared with about 1.5% for transrectal biopsy.⁷

A large registry study looking at different biopsy techniques found that systematic transrectal biopsy carried a 4% infection rate within seven days. Transperineal MRI-fusion biopsy had significantly fewer infections even though it typically took more tissue cores.⁸ The number of cores taken does not appear to meaningfully increase the risk of infection.⁹ What matters far more is the route the needle takes.

If you are scheduling a biopsy and your institution offers a transperineal approach, it is reasonable to ask about it. Many major urology guidelines now recommend transperineal biopsy as the preferred technique specifically because of the infection advantage. The question of infection timing still applies with transperineal biopsy, though events that do occur still tend to appear within the first week, even though they are much rarer.

Who Is Most at Risk

Not everyone faces the same odds. A population-based register study identified several factors that moderately increase infection risk, including diabetes, a urinary tract infection in the past year, and recent antibiotic use. Among patients with none of these risk factors, the infection rate after transrectal biopsy was about 4%. For men with three or four of these risk factors, the rate climbed to about 12%.¹⁰

The risk factors identified in that nationwide study included diabetes, medications for lower urinary tract symptoms, immunosuppressive therapy including corticosteroids, and use of urinary tract antibiotics in the preceding year. A related analysis from the same registry found that having a positive urine culture in the past 12 to 24 months and recent fluoroquinolone use were also moderately strong predictors of post-biopsy infection.¹¹

The last point is somewhat counterintuitive: recent antibiotic use increases infection risk rather than decreasing it. This is because prior antibiotic exposure selects for resistant bacteria in the gut, which are exactly the bacteria that the biopsy needle can introduce into the prostate and bloodstream. A man who took a course of fluoroquinolones a few months ago is more likely to carry fluoroquinolone-resistant bacteria in his rectum, making standard prophylaxis less effective.

Why Antibiotic Prophylaxis Sometimes Fails

Standard prophylaxis for transrectal biopsy has traditionally been a fluoroquinolone like ciprofloxacin, but this approach is increasingly unreliable. The germ behind almost all post-biopsy infections is E. coli, and fluoroquinolone-resistant E. coli has become alarmingly common. In one study, nearly 88% of culture-positive post-biopsy infections involved quinolone-resistant bacteria, and about 30% were also resistant to extended-spectrum cephalosporins.¹²

Carrying fluoroquinolone-resistant bacteria in the rectum roughly quadruples the risk of post-biopsy infection and roughly quintuples the risk of hospitalization for that infection, according to one large study.¹³ Another study found that 86% of gram-negative organisms isolated after post-biopsy infections were fluoroquinolone-resistant.¹⁴ Some of these resistant E. coli strains are also resistant to gentamicin and other backup antibiotics.¹⁵

This is the main reason the field is moving toward two strategies simultaneously: switching to the transperineal route (which avoids rectal bacteria entirely) and, when transrectal biopsy is still performed, using targeted prophylaxis based on a rectal swab taken before the procedure.

Smarter Prevention Strategies

The idea behind targeted prophylaxis is straightforward: instead of guessing which antibiotic will work, culture the patient’s rectal bacteria a week or so before the biopsy and choose an antibiotic that the bacteria are actually sensitive to. Randomized studies have shown this approach substantially reduces infections. One prospective trial found that targeted prophylaxis based on rectal swab cultures reduced the risk of post-biopsy infection by more than fivefold compared with standard empirical prophylaxis.¹⁶ Another randomized study confirmed that targeted antibiotics, frequently third-generation cephalosporins chosen based on the culture, significantly reduced febrile urinary infections after biopsy.¹⁷

Another measure gaining traction is rectal cleansing with povidone-iodine (the brown antiseptic solution) immediately before a transrectal biopsy. A meta-analysis found that adding povidone-iodine rectal disinfection to standard antibiotic prophylaxis cut the overall rate of infectious complications by about 44% and reduced fever by about half.¹⁸ The benefit for sepsis specifically did not quite reach statistical significance, but the overall infection reduction was clear. Combining antibiotic prophylaxis, rectal swab-guided drug selection, and povidone-iodine rectal preparation represents the current best-practice layered approach for transrectal biopsy.¹⁹

Some institutions have also begun routinely screening urine cultures before biopsy. In one large series, about 5% of pre-biopsy urine cultures came back positive, and those patients could be treated or have their antibiotics adjusted before the procedure.²⁰ Whether this meaningfully reduces post-biopsy infections beyond what rectal swab-guided prophylaxis achieves is still debated, but it is another layer of precaution some urologists use.

Rare Infections That Show Up Late

While the first week accounts for the vast majority of infections, there are uncommon complications that can present later and in unexpected locations. Case reports describe spondylodiscitis, an infection of the vertebral discs and adjacent bone, developing after transrectal biopsy. In one case, a 71-year-old man developed fever and back pain within 24 hours, but the spinal infection with an associated psoas muscle abscess was not diagnosed until imaging was performed.²¹ Another case report documented spondylodiscitis with both an epidural abscess and psoas muscle abscess after biopsy, noting that these symptoms, particularly back pain and lower-limb weakness, are easily mistaken for musculoskeletal problems and may not be recognized as infection-related.²²

Even more unusual complications have been documented, including pylephlebitis (infected blood clots in the portal vein) with subsequent splenic abscess.²³ These cases are genuinely rare, but they matter because they can present days to weeks after the biopsy and may not be immediately connected to the procedure. If you develop unexplained fever, persistent back pain, or abdominal symptoms in the weeks following a prostate biopsy, mention the biopsy to whatever doctor you see, even if the symptom does not seem related. The connection is easy to miss.

What to Do Before and After the Procedure

If you have an upcoming prostate biopsy, a few practical considerations can help reduce your risk and ensure that any infection is caught early:

Ask about approach: if transperineal biopsy is available, it carries a much lower infection risk and may not even require antibiotic prophylaxis in some protocols
Disclose your history: tell your urologist about any recent antibiotic use, prior urinary infections, diabetes, or immunosuppressive medications, as all of these affect your risk profile
Rectal swab: if you are having a transrectal biopsy, ask whether a pre-procedure rectal culture is part of your center’s protocol, since it allows targeted rather than empirical antibiotic selection
Take prophylaxis as directed: if antibiotics are prescribed before and after the procedure, complete the course exactly as instructed
Monitor temperature: check your temperature twice daily for the first week, and treat any reading at or above 38°C with chills as an emergency

The cost of a post-biopsy infection extends beyond the immediate health scare. Hospital admissions for sepsis after biopsy have been estimated to cost anywhere from roughly $8,700 to $19,000 per case.⁵ More importantly, sepsis carries real risks of ICU admission and, in rare cases, death. Prevention is far better than treatment, and the data increasingly point to the transperineal route and targeted prophylaxis as the most reliable ways to keep the risk as low as possible.